UBS Group’s SeaStar Medical Holding Corp Warrant ICUCW Stock Holding History

UBS Group’s Portfolio ICUCW Stock Details ICUCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14	Buy	801 +84	+12%	+$2	﹤0.01%	10308
2026 Q1	$21	Buy	+717	New	+$18	﹤0.01%	10284
2025 Q4	–	Sell	-560	Closed	-$15	–	10825
2025 Q3	$15	Sell	560 -248	-31%	-$9	﹤0.01%	10163
2025 Q2	$16	Buy	+808	New	+$25	﹤0.01%	10132
2024 Q2	–	Sell	-22,552	Closed	-$3.29K	–	9765
2024 Q1	$3.29K	Buy	22,552 +21,655	+2,414%	+$2.57K	﹤0.01%	7751
2023 Q4	$27	Sell	897 -80	-8%	-$3	﹤0.01%	9052
2023 Q3	$14	Buy	+977	New	+$26	﹤0.01%	9174
2023 Q2	–	Sell	-5,079	Closed	-$376	–	9221
2023 Q1	$376	Buy	5,079 +4,296	+549%	+$471	﹤0.01%	9057
2022 Q4	$70	Sell	783 -5,798	-88%	-$578	﹤0.01%	10444
2022 Q3	$0	Sell	6,581 -554	-8%	-$46	﹤0.01%	10600
2022 Q2	$1K	Sell	7,135 -716	-9%	-$104	﹤0.01%	9882
2022 Q1	$2K	Sell	7,851 -3,301	-30%	-$878	﹤0.01%	9637
2021 Q4	$5K	Buy	11,152 +6,799	+156%	+$3.39K	﹤0.01%	9396
2021 Q3	$2K	Buy	4,353 +24	+0.6%	+$12	﹤0.01%	8960
2021 Q2	$2K	Buy	+4,329	New	+$1.8K	﹤0.01%	8949

Other funds holding ICUCW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $128M AUM 19.21% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

CCA

Cruiser Capital Advisors Stamford, Connecticut $162M AUM 78.28% 1-Year Est. Return

UBS Group's ICUCW Position: Q2 2026 in Review

UBS Group increased its SeaStar Medical Holding Corp Warrant (ICUCW) stake by 12% in Q2 2026, buying an estimated $2 and bringing the position to 801 shares worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #10308.

UBS Group first reported a position in ICUCW in Q2 2021 and has held it in 15 quarters since. The position peaked at $5K in Q4 2021. 15 funds tracked by Wall St. Rank hold ICUCW as of Q2 2026.

UBS Group held 801 shares of SeaStar Medical Holding Corp Warrant worth $14 as of Q2 2026.
UBS Group bought 84 SeaStar Medical Holding Corp Warrant shares in Q2 2026, an estimated $2.
SeaStar Medical Holding Corp Warrant made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10308 holding.
UBS Group first reported a position in SeaStar Medical Holding Corp Warrant in Q2 2021 and has held it in 15 quarters since.
UBS Group's SeaStar Medical Holding Corp Warrant position peaked at $5K in Q4 2021.
15 funds tracked by Wall St. Rank held SeaStar Medical Holding Corp Warrant as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.